Form 483

Fareva Amboise Form 483, 2018-05-25

FDA issued a Form 483 to Fareva Amboise on 2018-05-25 with 4 public-safe observations.

483· Form 483 issuedAnimal Drugs & Feeds4 observations

Fareva Amboise · Poce Sur Cisse, France · Issued May 25, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

25 May 2018
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Taichun Qin

25 May 2018
21 CFR 211.42(a)

Buildings of Suitable Size, Construction, Location

Cited by Taichun Qin

25 May 2018
21 CFR 211.22(a)

Approve or reject components, products

Cited by Taichun Qin

25 May 2018
21 CFR 211.68(b)

Computer control of master formula records

Cited by Taichun Qin

Inspected site

FAFareva AmboisePoce Sur Cisse, France

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere